Search Results - Fabrizio Pane

Refine Results
  1. 1
    SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection

    SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection by Elisabetta Abruzzese, Luigia Luciano, Francesco D’Agostino, Malgorzata Monika Trawinska, Fabrizio Pane, Paolo de Fabritiis

    Published 2020
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  2. 2
    Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation

    Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Ita... by Giovanni Barosi, Alberto Bosi, Maria P. Abbracchio, Romano Danesi, Armando A. Genazzani, Paolo Corradini, Fabrizio Pane, S Tura

    Published 2011
    Get full text Get full text
    Editorial
    Save to List
    Saved in:
  3. 3
    Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making

    Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy deci... by Felicetto Ferrara, Giovanni Barosi, Adriano Venditti, Emanuele Angelucci, Marco Gobbi, Fabrizio Pane, Patrizia Tosi, Pier Luigi Zinzani, S Tura

    Published 2013
    Get full text Get full text
    Editorial
    Save to List
    Saved in:
  4. 4
    Hashimoto Thyroiditis in Primary Thyroid Non-Hodgkin Lymphoma

    Hashimoto Thyroiditis in Primary Thyroid Non-Hodgkin Lymphoma by Antonio Travaglino, Mirella Pace, Silvia Varricchio, Luigi Insabato, Claudia Giordano, Marco Picardi, Fabrizio Pane, Stefania Staibano, Massimo Mascolo

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Metabolic Tumor Volume Assessed by <sup>18</sup>F-FDG PET/CT for the Prediction of Outcome in Patients with Multiple Myeloma

    Metabolic Tumor Volume Assessed by <sup>18</sup>F-FDG PET/CT for the Prediction of Outcome in Patients with Multiple Myeloma by Rosa Fonti, Michele Larobina, Silvana Del Vecchio, Serena De Luca, Rossella Fabbricini, Lucio Catalano, Fabrizio Pane, Marco Salvatore, Leonardo Pace

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics

    Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics by Josée Golay, Gianpietro Semenzato, Alessandro Rambaldi, Robin Foà, Gianluca Gaïdano, Enrica Gamba, Fabrizio Pane, Antonio Pinto, Giorgina Specchia, Francesco Zaja, Mario Regazzi

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis

    Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis by Giuseppe Saglio, Fabrizio Pane, Enrico Gottardi, Ferdinando Frigeri, MR Buonaiuto, A Guerrasio, Daniela De Micheli, Adele Parziale, MN Fornaci, Giovanni Martinelli, Francesco Salvatore

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Eltrombopag for post-transplant cytopenias due to poor graft function

    Eltrombopag for post-transplant cytopenias due to poor graft function by Serena Marotta, Luana Marano, Patrizia Ricci, Fabiana Cacace, Camilla Frieri, Luigia Simeone, Fabio Trastulli, Selenia Vitiello, Flora Cardano, Fabrizio Pane, Antonio M. Risitano

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Navigating acute myeloid leukemia towards better outcomes: Treatment pathways and challenges for patients ineligible for intensive chemotherapy

    Navigating acute myeloid leukemia towards better outcomes: Treatment pathways and challenges for patients ineligible for intensive chemotherapy by Raffaele Palmieri, Anna Candoni, Francesco Di Raimondo, Giuseppe Rossi, Massimo Breccia, Fabrizio Pane, Paola Volpicelli, Benedetta Neri, Paola Finsinger, Morena Caira, Felicetto Ferrara

    Published 2025
    Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia

    Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia by Concetta Quintarelli, Gianpietro Dotti, Biagio De Angelis, Valentina Hoyos, Martha P. Mims, Luigia Luciano, Helen E. Heslop, Cliona M. Rooney, Fabrizio Pane, Barbara Savoldo

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Generation of Epstein-Barr virus–specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)

    Generation of Epstein-Barr virus–specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506) by Biagio De Angelis, Gianpietro Dotti, Concetta Quintarelli, Leslie E. Huye, Lan Zhang, Ming Zhang, Fabrizio Pane, Helen E. Heslop, Malcolm K. Brenner, Cliona M. Rooney, Barbara Savoldo

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma

    Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected... by Novella Pugliese, Maria Di Perna, Immacolata Cozzolino, Giuseppe Ciancia, Guido Pettinato, Pio Zeppa, Valeria Varone, Stefania Masone, Claudio Cerchione, Roberta Della Pepa, Luigia Simeone, Claudia Giordano, Vincenzo Martinelli, Claudia Salvatore, Fabrizio Pane, Marco Picardi

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells

    High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells by Concetta Quintarelli, Gianpietro Dotti, Sayyeda T. Hasan, Biagio De Angelis, Valentina Hoyos, Santa Errichiello, Martha P. Mims, Luigia Luciano, Jessica A. Shafer, Ann M. Leen, Helen E. Heslop, Cliona M. Rooney, Fabrizio Pane, Malcolm K. Brenner, Barbara Savoldo

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper

    Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwe... by Loredana Sarmati, Massimo Andreoni, Guido Antonelli, William Arcese, Raffaele Bruno, Nicola Coppola, G.B. Gaeta, Massimo Galli, Corrado Girmenia, Małgorzata Mikulska, Fabrizio Pane, Carlo Federico Perno, Marco Picardi, Massimo Puoti, Alessandro Rambaldi, Valentina Svicher, Gloria Taliani, Giuseppe Gentile

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party

    Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party by Fausto Castagnetti, Francesca Palandri, Marilina Amabile, Nicoletta Testoni, Simona Luatti, Simona Soverini, Ilaria Iacobucci, Massimo Breccia, Giovanna Rege Cambrin, Fabio Stagno, Giorgina Specchia, Piero Galieni, F. Iuliano, Fabrizio Pane, Giuseppe Saglio, Giuliana Alimena, Giovanni Martinelli, Michele Baccarani, Gianantonio Rosti

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Establishment and Validation of Analytical Reference Panels for the Standardization of Quantitative BCR-ABL1 Measurements on the International Scale

    Establishment and Validation of Analytical Reference Panels for the Standardization of Quantitative BCR-ABL1 Measurements on the International Scale by Helen White, John Hedges, Israel Bendit, Susan Branford, Dolors Colomer, Andreas Hochhaus, Timothy P. Hughes, Suzanne Kamel‐Reid, Dong‐Wook Kim, Vijay Modur, Martin Müller, Kátia Bórgia Barbosa Pagnano, Fabrizio Pane, Jerry Radich, Nicholas C.P. Cross, Emmanuel Labourier

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

    Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera by Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Martin Grießhammer, Tamás Masszi, Simon Durrant, Francesco Passamonti, Claire Harrison, Fabrizio Pane, Pierre Zachée, Ruben A. Mesa, Shui He, Mark M. Jones, William M. Garrett, Jingjin Li, Ulrich Pirron, Dany Habr, Srđan Verstovšek

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Changes in quality of life and disease‐related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy

    Changes in quality of life and disease‐related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy by Ruben A. Mesa, Srđan Verstovšek, Jean‐Jacques Kiladjian, Martin Grießhammer, Tamás Masszi, Simon Durrant, Francesco Passamonti, Claire Harrison, Fabrizio Pane, Pierre Zachée, Hui‐Ling Zhen, Mark M. Jones, Shreekant Parasuraman, Jingjin Li, Isabelle Côté, Dany Habr, Alessandro M. Vannucchi

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials

    Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison o... by Susan Branford, Linda Fletcher, Nicholas C.P. Cross, Martin Müller, Andreas Hochhaus, Dong‐Wook Kim, Jerald P. Radich, Giuseppe Saglio, Fabrizio Pane, Suzanne Kamel‐Reid, Y. Lynn Wang, Richard D. Press, Kevin Lynch, Zbigniew Rudzki, John M. Goldman, Timothy P. Hughes

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    ABL Mutations in Late Chronic Phase Chronic Myeloid Leukemia Patients With Up-Front Cytogenetic Resistance to Imatinib Are Associated With a Greater Likelihood of Progression to Blast Crisis and Shorter Survival: A Study by the GIMEMA Working Party on Chronic Myeloid Leukemia

    ABL Mutations in Late Chronic Phase Chronic Myeloid Leukemia Patients With Up-Front Cytogenetic Resistance to Imatinib Are Associated With a Greater Likelihood of Progression to Bl... by Simona Soverini, Giovanni Martinelli, Gianantonio Rosti, Simona Bassi, Marilina Amabile, Angela Poerio, Barbara Giannini, Elena Trabacchi, Fausto Castagnetti, Nicoletta Testoni, Simona Luatti, Antonio De Vivo, Daniela Cilloni, Barbara Izzo, Milena Fava, Elisabetta Abruzzese, Daniele Alberti, Fabrizio Pane, Giuseppe Saglio, Michele Baccarani

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: